Hanover Insurance Group CEO John Roche sells $1.84 million in stock

Published 04/03/2025, 22:30
Hanover Insurance Group CEO John Roche sells $1.84 million in stock

On March 3, John C. Roche, President and CEO of Hanover Insurance Group, Inc. (NYSE:THG), executed significant stock transactions as reported in a recent SEC filing. Roche sold shares totaling approximately $1.84 million. The shares were sold at prices ranging from $170.91 to $172.66, near the stock’s 52-week high of $173.30. According to InvestingPro data, THG has delivered an impressive 38.29% return over the past year.

Additionally, Roche exercised options to acquire 10,706 shares at a price of $77.91 per share, valued at approximately $834,104. Following these transactions, Roche’s direct ownership stands at 124,277.851 shares, not including 14,454 shares held by his spouse. With a current market capitalization of $6.1 billion and a P/E ratio of 14.36, THG trades slightly above its Fair Value based on InvestingPro comprehensive analysis.

These transactions were executed under a pre-established Rule 10b5-1 Trading Plan adopted on November 5, 2024, which allows insiders to set up a predetermined plan for trading stocks. For deeper insights into THG’s valuation and performance metrics, including 8 additional ProTips and detailed financial analysis, visit InvestingPro.

In other recent news, Hanover Insurance Group reported fourth-quarter earnings that significantly exceeded analyst estimates, with operating earnings of $5.32 per share, surpassing the consensus estimate of $3.36 per share. Revenue increased by 7.4% year-over-year to $1.45 billion, exceeding expectations of $1.43 billion. The company’s combined ratio improved to 89.2%, indicating enhanced underwriting profitability. Additionally, net investment income rose by 23.4% to $100.7 million due to higher bond reinvestment rates and increased cash flows. For the full year 2024, Hanover reported operating earnings of $13.34 per share on revenue of $6.08 billion, with a 14.9% increase in book value per share to $79.18. In terms of analyst activity, BMO Capital Markets raised its price target for Hanover Insurance to $189, maintaining an Outperform rating, while Keefe, Bruyette & Woods increased their target to $179, keeping a Market Perform rating. Oppenheimer also adjusted their price target to $185, maintaining an Outperform rating, following Hanover’s strong fourth-quarter results and positive future guidance. In executive news, Jeffrey M. Farber was appointed as Hanover’s new Principal Accounting Officer, replacing Warren E. Barnes, who is retiring.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.